ENFORCEMENT DECREE OF THE INFECTIOUS DISEASE CONTROL AND PREVENTION ACT

Article 1(Purpose) #

The purpose of this Decree is to prescribe matters mandated by the Infectious Disease Control and Prevention Act and other matters necessary for the enforcement of said Act.

Article 1-2(Establishment and operation of organizations supporting infectious disease control projects) #

(1) Pursuant to Article 8(1) of the Infectious Disease Control and Prevention Act (hereinafter referred to as the "Act"), the central organization supporting infectious disease control projects shall be established within the Korea Disease Control and Prevention Agency, and a City/Do organization supporting infectious disease control projects shall be established within the Special Metropolitan City, a Metropolitan City, a Special Self-Governing City, a Do, and a Special Self-Governing Province (hereinafter referred to as "City/Do"), as determined by the Commissioner of Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020; Sep. 26, 2023>

(2) The members of the central organization supporting infectious disease control projects shall be commissioned by the Commissioner of Korea Disease Control and Prevention Agency from among any of the following persons: <Amended on Sep. 11, 2020>

1. A person who has worked in infectious disease-related areas as a member of medical personnel defined in subparagraph 1 of Article 2 of the Medical Service Act;

2. A person who has worked in infectious disease-related areas at universities prescribed in the Higher Education Act or public institutions prescribed in the Act on the Management of Public Institutions;

3. A person with considerable knowledge and experience in the prevention and control of infectious diseases;

4. A person with considerable knowledge and experience in the areas of epidemiological investigation, disease control, etc.;

5. A person deemed by the Commissioner of Korea Disease Control and Prevention Agency as essential to supporting infectious disease control projects.

(3) If necessary for conducting its duties, the central organization supporting infectious disease control projects may request the relevant institutions, organizations, experts, etc. to submit materials, opinions, etc.

(4) The central organization supporting infectious disease control projects shall report the status of its activities, etc. to the Commissioner of Korea Disease Control and Prevention Agency, as determined by the Commissioner of Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(5) The Commissioner of Korea Disease Control and Prevention Agency may provide the central organization supporting infectious disease control projects with subsidies to cover the following costs within the budget: <Amended on Sep. 11 2020; Sep. 16 2025>

1. Costs incurred in the collection of materials, investigation, analysis, consulting, etc.;

2. Travel expenses, allowances, etc. incurred in the promotion of domestic and international cooperative projects;

3. Other expenses the Commissioner of Korea Disease Control and Prevention Agency deems particularly necessary for conducting duties.

(6) Except as provided in paragraphs (2) through (5), details necessary for establishment, operation, subsidization, etc. of the central organization supporting infectious disease control projects shall be determined by the Commissioner of Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(7) Paragraphs (2) through (6) shall apply mutatis mutandis to commissioning of members, requests for submission of materials, reporting on the status of activities, subsidization, etc. of a City/Do organization supporting infectious disease control projects. In such cases, "Commissioner of Korea Disease Control and Prevention Agency" shall be construed as "Special Metropolitan City Mayor, Metropolitan City Mayor, Special Self-Governing City Mayor, Do Governor, or Special Self-Governing Province Governor (hereinafter referred to as "Mayor/Do Governor"), and "central organization supporting infectious disease control projects" as "City/Do organization supporting infectious disease control projects". <Amended on Sep. 11, 2020; Sep. 26, 2023>

[This Article Added on Jun. 28, 2016]

Article 1-3(Designation of infectious disease specialty hospitals) #

(1) A medical institution (referring to a medical institution prescribed in Article 3 of the Medical Service Act; hereinafter referred to as "medical institution") eligible to be designated as an infectious disease specialty hospital prescribed in Article 8-2(1) of the Act (hereinafter referred to as the "central infectious disease hospital") shall be a medical institution the Minister of Health and Welfare determines and publicly notifies, among general hospitals or superior general hospitals under Article 3-3 or 3-4 of the Medical Service Act.

(2) The standards for designation of the central infectious disease hospital are as specified in Appendix 1.

(3) Where the Minister of Health and Welfare designates the central infectious disease hospital, he or she may apply conditions to the standards for designation, conduct of duties, etc. thereof.

(4) If the Minister of Health and Welfare has designated the central infectious disease hospital, he or she shall deliver a certificate of designation and post the details of such designation on the website of the Ministry of Health and Welfare. <Amended on Sept. 16, 2025>

(5) The central infectious disease hospital shall report the status of performance of duties, etc. to the Minister of Health and Welfare each quarter, as prescribed by the Minister of Health and Welfare.

(6) The Minister of Health and Welfare may subsidize the central infectious disease hospital for building costs, operating costs, installation costs, etc., in consultation with the Minister of Planning and Budget under Article 8-2 (3) of the Act. <Amended on Dec. 30, 2025>

(7) Except as provided in paragraphs (3) through (6), details necessary for procedures for designation, subsidies for expenses, etc. of the central infectious disease hospital shall be determined and publicly notified by the Minister of Health and Welfare.

[This Article Added on Jun. 28, 2016]

Article 1-4(Designation of regional infectious disease specialty hospitals) #

(1) A medical institution eligible to be designated as a regional infectious disease specialty hospital under Article 8-2(2) of the Act (hereinafter referred to as a "regional infectious disease hospital") shall be a medical institution determined and publicly notified by the Commissioner of Korea Disease Control and Prevention Agency among the general hospitals or superior general hospitals prescribed in Article 3-3 or 3-4 of the Medical Service Act. <Amended on Sep. 11, 2020>

(2) The standards for designating regional infectious disease hospitals are as prescribed in Appendix 1-2.

(3) Where the Commissioner of Korea Disease Control and Prevention Agency designates a regional infectious disease hospital under Article 8-2(2) of the Act, he or she shall consider the following matters comprehensively: <Amended on Sep. 11, 2020>

1. The level of distribution of medical service resources in the relevant region;

2. The population and the range of habitat of the relevant region;

3. The frequency of outbreak and the level of control of infectious diseases in the relevant region;

4. The vicinity to harbors, airports, etc. in the relevant region;

5. Other matters deemed by the Commissioner of Korea Disease Control and Prevention Agency as particularly necessary in connection with the control of infectious diseases by region.

(4) If necessary to designate a regional infectious disease hospital, the Commissioner of Korea Disease Control and Prevention Agency may hear the opinions of the heads of local governments, relevant public institutions, organizations, etc. or request them to submit materials. <Amended on Sep. 11, 2020>

(5) Article 1-3(3) through (7) shall apply mutatis mutandis to the public notice of detailed matters necessary for imposition of conditions of designation, delivery of certificates of designation, public announcement of the fact of designation, reporting on the progress of implementation of duties, subsidization, procedures for designation, etc. of regional infectious disease hospitals. In such cases, the "Minister of Health and Welfare" shall be construed as the "Commissioner of the Korea Disease Control and Prevention Agency", "central infectious disease hospitals" as "regional infectious disease hospitals', and the "Ministry of Health and Welfare" as the "Korea Disease Control and Prevention Agency", respectively. <Amended on Sep. 11, 2020; Sep. 16, 2025>

Article 1-5(Establishment and operation of medical resource information system) #

Information to be established and operated in the medical resource information system under Article 8-2(4) shall be as follows:

1. Information on each medical institution, including the number of admitted and discharged patients, the number of beds, and the status of medical equipment and personnel;

2. Information related to admission or transfer, including the name, resident registration number, address, telephone number, and medical records of patients with an infectious disease, persons suspected of an infectious disease, or a pathogen carrier (hereinafter referred to as "infectious disease patients, etc.");

3. Other information that the Minister of Health and Welfare deems necessary for the efficient management of medical resources and for the collection, analysis, and utilization of infectious disease information.

[This Article Added on Sep. 30, 2025]

[Previous Article 1-5 moved to Article 1-6 <Sep. 30, 2025>]

Article 1-6(Formulation of measures for controlling resistant bacteria) #

(1) Where the Minister of Health and Welfare intends to change important matters the Minister of Health and Welfare determines among the matters included in the measures for controlling resistant bacteria prescribed in Article 8-3(1) of the Act (hereinafter referred to as "measures for controlling resistant bacteria"), he or she shall submit such changes for deliberation by the Infectious Disease Control Committee prescribed in Article 9(1) of the Act.

(2) Where the Minister of Health and Welfare formulates or changes measures for controlling resistant bacteria, he or she shall post such measures on the website of the Ministry of Health and Welfare and inform the heads of the relevant central administrative agencies, the President of the Health Insurance Review and Assessment Service under the National Health Insurance Act and the heads of other resistant bacteria-related institutions, corporations and organizations of the details thereof.

(3) Except as provided in paragraphs (1) and (2), detailed matters necessary for the formulation and change of measures for controlling resistant bacteria shall be determined by the Minister of Health and Welfare.

[This Article Added on May 29, 2017]

[Moved from Article 1-5; previous Article 1-6 moved to Article 1-7 <Sep. 30, 2025>]

Article 1-7(Establishment and operation of Emergency Operations Center) #

(1) The Emergency Operations Center established pursuant to Article 8-5 of the Act (hereinafter referred to as "Emergency Operations Center") shall meet all the following requirements for establishment and operation:

1. Establishing an information and communications system for promptly collecting and disseminating information on infectious diseases, comprehensively managing emergency conditions related to infectious diseases, etc.;

2. Securing facilities and equipment for effectively responding to emergency conditions related to infectious diseases and a system for operating and managing such facilities and equipment;

3. Securing dedicated personnel necessary to operate the Emergency Operations Center around the clock;

4. Preparing operational regulations and work manuals to facilitate the operation of the Emergency Operations Center.

(2) Detailed matters related to establishing and operating the Emergency Operations Center shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

[This Article Added on Jun. 12, 2018]

[Moved from Article 1-6 <Sep. 30, 2025>]

Article 2(Duties, and terms of office, of members of Infectious Disease Control Committee) #

(1) The Chairperson of the Infectious Disease Control Committee (hereinafter referred to as the "Committee") established under Article 9(1) of the Act, shall represent the Committee and exercise general control over the administrative affairs thereof. <Amended on Jun. 28, 2016>

(2) The vice-chairperson of the Committee shall assist the Chairperson and act on the Chairperson's behalf if the Chairperson is unable to perform any of his or her duties due to an extenuating circumstance.

(3) The term of office of any commissioned member of the Committee shall be two years.

(4) If a vacancy occurs in the office of Committee member, the term of office of a member filling the vacancy shall be the remainder of his or her predecessor’s term of office.

Article 3(Meetings) #

(1) Committee meetings shall be convened upon request by the Commissioner of the Korea Disease Control and Prevention Agency or a majority of the members thereof, or by the Chairperson when he or she deems necessary. <Amended on Sep. 11, 2020>

(2) A majority of the members of the Committee shall constitute a quorum at Committee meetings and resolutions shall be passed with the concurrent vote of a majority of members present.

(3) Deleted. <Sep. 11, 2020>

(4) If deemed necessary for conducting its affairs, the Committee may request relevant public officials or experts to appear before the Committee to state their opinions.

Article 4(Executive secretary) #

The Committee shall have one executive secretary to administer the clerical work thereof, who shall be appointed by the Chairperson from among public officials belonging to the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

Article 5(Payment of allowances) #

A member who attends a Committee meeting may be paid allowances and reimbursed for travel expenses, within the budget; provided, this shall not apply where a member who is a public official attends a Committee meeting directly in connection with any of his or her official duties.

Article 6(Detailed operating rules) #

Except as otherwise expressly provided for in this Decree, matters necessary for operating the Committee shall be determined by the Chairperson, following a resolution by the Committee.

Article 7(Composition of advisory committees) #

(1) Pursuant to Article 10(3) of the Act, the Committee shall establish the following advisory committees for each field: <Amended on Jan. 6, 2015; May 29, 2017; Apr. 2, 2020; Jun. 8, 2021; Oct. 4, 2022>

1. The advisory committee on vaccination;

2. The advisory committee on vaccination injury compensation;

3. The advisory committee on acquired immunodeficiency syndrome;

4. The advisory committee on tuberculosis;

5. The advisory committee on epidemiological investigation;

6. The advisory committee on zoonoses;

6-2. The advisory committee on infection related to medical care;

7. The advisory committee on infectious disease crisis control;

7-2. The advisory committee on diagnosis and analysis of infectious diseases;

8. The advisory committee on infectious disease research and planning;

9. The advisory committee on antibiotic resistance;

10. The advisory committee on quarantine.

(2) Each expert committee shall be composed of up to 25 members, including 1 chairperson. <Amended on Apr. 2, 2020>

(3) The chairperson of each advisory committee shall be appointed by the Chairperson of the Committee, from among Committee members.

(4) Members of each advisory committee shall be appointed by the Chairperson of the Committee, from among Committee members, or commissioned by the Chairperson of the Committee, from among those recommended by the relevant academic society or organization or by Committee members.

Article 8(Meetings and operation of advisory committees) #

(1) Meetings of an advisory committee shall be convened upon request by the Chairperson of the Committee, by a majority of the members of the advisory committee, or by the chairperson of the advisory committee when he or she deems necessary.

(2) A majority of the members of an advisory committee shall constitute a quorum at committee meetings and resolutions shall be passed with the concurrent vote of a majority of members present.

(3) The chairperson of an advisory committee shall report the resolutions deliberated on and adopted by the advisory committee to the Chairperson of the Committee. <Amended on Jan. 6, 2015>

(4) Except as provided in this Decree, matters necessary for operating each advisory committee shall be determined by the chairperson of the advisory committee, following a resolution by the advisory committee.

Article 9(Other zoonoses) #

"Other zoonoses prescribed by Presidential Decree" in Article 14(1)4 of the Act means animal influenza. <Amended on Jan. 6, 2016>

Article 10(Public institutions) #

"Public institutions prescribed by Presidential Decree" in the former part of Article 16(7) of the Act means the Health Insurance Review and Assessment Service and the National Health Insurance Service established under the National Health Insurance Act. <Amended on Jan. 6, 2016>

Article 11(Information to be provided) #

The information that may be requested under Article 16 (7) may include the following matters: <Amended on Jan. 6, 2016; Sep. 30, 2025>

1. The name, resident registration number, sex, address, telephone number, occupation, name of the infectious disease, date of onset, and date of diagnosis of a patient with an infectious disease, etc.;

2. The name, location, and telephone number of the medical institution that diagnosed the case of a patient of an infectious disease, etc. and the name of the physician who made such diagnosis.

Article 12(Details of epidemiological investigations) #

(1) Matters to be identified through epidemiological investigations under Article 18(1) of the Act shall be as follows: <Amended on Dec. 14, 2021>

1. The personal information of patients of an infectious disease, etc. and persons suspected of contracting an infectious disease;

2. The date and place where a patient, etc. was infected with an infectious disease;

3. The cause and route of infection for an infectious disease;

4. The medical records of patients of an infectious disease, etc. and persons suspected of contracting an infectious disease;

5. Other matters necessary to reveal the cause of an infectious disease.

(2) Matters to be identified through epidemiological investigations under Article 29 of the Act shall be as follows:

1. The personal information of persons showing adverse reactions to vaccinations;

2. The vaccination service institution, date of vaccination, and details of vaccination;

3. The record of medical treatment for adverse reactions to vaccinations;

4. The details of vaccines;

5. Other matters necessary to reveal the causes of adverse reactions to vaccinations.

Article 13(Timing of epidemiological investigations) #

An epidemiological investigation specified in Article 18(1) and 29 of the Act shall be conducted, upon occurrence of the relevant grounds therefor classified as follows: <Amended on Jun. 28, 2016; Sep. 11, 2020>

1. Where the Commissioner of the Korea Disease Control and Prevention Agency is required to conduct an epidemiological investigation:

a. Where the epidemiological investigation is to be conducted simultaneously in at least two Cities/Dos;

b. Where an urgent investigation is necessary, as to the outbreak or prevalence of an infectious disease or adverse reactions to vaccinations;

c. Where an epidemiological investigation conducted by a Mayor/Do Governor is deemed insufficient or it is deemed impracticable for a Mayor/Do Governor to conduct an epidemiological investigation;

2. Where a Mayor/Do Governor or the head of a Si/Gun/Gu (referring to an autonomous Gu; hereinafter the same shall apply) is required to conduct an epidemiological investigation:

a. Where an infectious disease is likely to occur and prevail within his or her jurisdiction;

b. Where an infectious disease is likely to occur and prevail outside his or her jurisdiction, but suspected to have an epidemiological link within his or her jurisdiction;

c. Where a case of an adverse reaction to a vaccination is found within his or her jurisdiction, thus making it necessary to conduct an investigation to identify the cause.

Article 14(Methods of epidemiological investigation) #

The methods of conducting epidemiological investigations under Article 18(1) and 29 of the Act shall be as set forth in Appendix 1-3. <Amended on Jun. 28, 2016>

Article 15(Composition of epidemiological investigation teams) #

(1) To conduct an epidemiological investigation under Article 18(1) and 29 of the Act, the central epidemiological investigation team shall be established in the Korea Disease Control and Prevention Agency, a City/Do epidemiological investigation team in a City/Do; and a Si/Gun/Gu epidemiological investigation team in a Si/Gun/Gu (a Gu refers to an autonomous Gu; hereinafter the same shall apply). <Amended on Sep. 11, 2020>

(2) The central epidemiological investigation team shall be comprised of at least 30 members, and a City/Do epidemiological investigation team and a Si/Gun/Gu epidemiological investigation team shall be comprised of at least 10 members, respectively. <Amended on Jan. 6, 2016; Dec. 14, 2021>

(3) A disease control officer appointed under Article 60 of the Act or an epidemiological investigation officer appointed under Article 60-2 of the Act shall serve as the chief of an epidemiological investigation team. <Added on Dec. 14, 2021>

(4) The members of each epidemiological investigation team shall be appointed or commissioned by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu respectively, from among the following persons: <Amended on Jan. 6, 2016; Sep. 11, 2020; Dec. 14, 2021; Aug. 18, 2023>

1. Public officials who take charge of disease control, epidemiological investigation, or vaccination services;

2. Epidemiological investigation officers or epidemiological investigation officer trainees under Article 60-2 of the Act;

3. Public health doctors employed under the Act on Special Measures for Health and Medical Services in Agricultural and Fishing Villages;

4. Medical personnel defined in Article 2(1) of the Medical Service Act;

5. Other experts, etc. in the field related to infectious diseases, etc., who are deemed necessary by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu for conducting an epidemiological investigation.

(5) Each epidemiological investigation team shall be operated by dividing into two sections of infectious diseases and adverse reactions to vaccinations, and matters necessary for the sectional operation shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020; Dec. 14, 2021>

Article 16(Functions of epidemiological investigation teams) #

(1) The functions of each epidemiological investigation team shall be as follows:

1. The central epidemiological investigation team:

a. Formulating, implementing, and evaluating an epidemiological investigation plan;

b. Developing the standards and methods for conducting epidemiological investigations;

c. Providing education and training for City/Do epidemiological investigation teams and Si/Gun/Gu epidemiological investigation teams;

d. Conducting epidemiological research on infectious diseases;

e. Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases and the cases of adverse reactions to vaccinations;

f. Providing technical guidance for and evaluation of City/Do epidemiological investigation teams;

2. City/Do epidemiological investigation teams:

a. Formulating, implementing, and evaluating an epidemiological investigation plan for each jurisdiction;

b. Developing detailed standards and methods for conducting epidemiological investigations in each jurisdiction;

c. Reporting the findings of epidemiological investigations in each jurisdiction, to the central epidemiological investigation team;

d. Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases, and for the cases of adverse reactions to vaccinations in each jurisdiction;

e. Providing technical guidance for and evaluation of Si/Gun/Gu epidemiological investigation teams;

3. Si/Gun/Gu epidemiological investigation teams:

a. Formulating and implementing an epidemiological investigation plan for each jurisdiction;

b. Reporting the findings of epidemiological investigations in each jurisdiction, to the relevant City/Do epidemiological investigation team;

c. Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases and the cases of adverse reactions to vaccinations in each jurisdiction.

(2) Each epidemiological investigation team member who conducts an epidemiological investigation shall carry a certificate of epidemiological investigator prescribed by Decree of the Ministry of Health and Welfare, and produce it to interested parties.

Article 16-2(Institutions or organizations required to present materials) #

"Institution or organization, etc. prescribed by Presidential Decree" in Article 18-4(1) of the Act means the following: <Amended on Jun. 28, 2016>

1. A medical institution;

2. The National Health Insurance Service established under Article 13 of the National Health Insurance Act;

3. The Health Insurance Review and Assessment Service established under Article 62 of the National Health Insurance Act.

[This Article Added on Jan. 6, 2016]

Article 16-3(Extent of request for assistance) #

The Commissioner of the Korea Disease Control and Prevention Agency may request the head of a relevant central administrative agency to dispatch its personnel and provide goods necessary for conducting an epidemiological investigation, to manage persons and institutions subject to epidemiological investigations, to conduct an examination and analyze information for identifying the source and route of infection, and provide other necessary assistance, pursuant to Article 18-4(3) of the Act. <Amended on Sep. 11, 2020; Aug. 18, 2023>

[This Article Added on Jan. 6, 2016]

Article 17(Implementation of infectious disease education) #

(1) The head of a State agency or the head of a local government who shall provide education for the prevention and control of infectious diseases and response to crisis (hereinafter referred to as "education on infectious diseases") pursuant to Article 18-5(1) of the Act shall provide education on infectious diseases to public officials, employees, etc. under his or her jurisdiction for at least one hour every year; provided, the following public officials and employees under his or her jurisdiction shall provide education on infectious diseases for at least hours prescribed in the relevant subparagraph:

1. Public officials and employees (excluding epidemiological investigation team members under subparagraph 2) belonging to regional healthcare institutions under the Community Health Care Act and public health clinics under the Act on Special Measures for Health and Medical Services in Agricultural and Fishing Villages and public health clinics under subparagraph 2: Four hours a year;

2. Epidemiological investigation team members appointed pursuant to Article 15(4)1 through 3: 10 hours a year.

(2) In order to provide infectious disease education pursuant to Article 18-5(2) of the Act, the head of a public institution under Article 4 of the Act on the Management of Public Institutions may formulate and implement a plan for infectious disease education, including persons subject to and hours of education.

(3) The contents of education on infectious diseases under Article 18-5(1) and (2) of the Act shall be as follows:

1. Current status of the system for responding to infectious disease crisis and the relevant statutes and regulations;

2. Major cases related to epidemic of infectious diseases and crisis response;

3. Other matters that the Commissioner of the Korea Disease Control and Prevention Agency deems necessary for the prevention and control of infectious diseases and response to crisis.

(4) Education on Infectious Diseases under Article 18-5(1) and (2) of the Act may be conducted by means of gathering education or Internet lectures, etc.

(5) The Commissioner of the Korea Disease Control and Prevention Agency may request relevant institutions, organizations, experts, etc. to provide necessary cooperation, such as consultation or provision of materials, for the development and dissemination of curricula under Article 18-5(3) of the Act.

Article 18(Matters for report on modification of permission for introducing high-risk pathogens) #

"Minor matters prescribed by Presidential Decree" in the proviso of Article 22(2) of the Act means the following: <Amended on Jun. 2, 2020>

1. The name, address and contact information of the person (limited to natural persons) permitted to introduce high-risk pathogens;

2. The name, address and contact information of the person (limited to legal persons) permitted to introduce high-risk pathogens and the name and contact address of the representative thereof;

3. The name, position and contact information of the manager who takes exclusive charge of high-risk pathogens.

Article 19(Designation of place to acquire high-risk pathogens) #

A person who intends to acquire and transfer high-risk pathogens under Article 22(3) of the Act shall designate the place of acquisition from among the places determined by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

Article 19-2(Permission for and report on establishment and operation of high-risk pathogen handling facilities) #

(1) The classification of safety control grades of high-risk pathogen handling facilities under Article 23(1) of the Act (hereinafter referred to as "high-risk pathogen handling facilities") as well as high-risk pathogen handling facilities subject to permission or reporting shall be as specified in Appendix 1-4. <Amended on Jun. 2, 2020>

(2) The Commissioner of the Korea Disease Control and Prevention Agency shall determine and publicly notify the standards for permitting or accepting reports on the establishment and operation of high-risk pathogen handling facilities with regard to each of the following matters by safety control grade of high-risk pathogen handling facilities: <Amended on Jun. 2, 2020; Sep. 11, 2020>

1. The types of high-risk pathogen handling facilities;

2. The equipment, personnel, and safety control necessary to inspect, possess, manage and transport high-risk pathogens;

3. The equipment, personnel, and safety control for facilities that can prevent harm to the human body during the process of inspecting, possessing, managing or transporting high-risk pathogens (hereinafter referred to as "facilities for preventing health harm").

(3) Any person who intends to establish and operate a high-risk pathogen handling facility subject to permission prescribed in Article 23(2) of the Act and Appendix 1-4 shall submit to the Commissioner of the Korea Disease Control and Prevention Agency an application for permission prescribed by Decree of the Ministry of Health and Welfare, along with the following documents: <Amended on Sep. 11, 2020>

1. Drawings and specifications of the high-risk pathogen handling facility or a copy thereof;

2. Documents certifying the scope of the high-risk pathogen handling facility, and the ownership or use rights thereto;

3. Basic drawings and specifications of a facility for preventing health harm, or a copy thereof;

4. Documents certifying compliance with the standards for permission prescribed in paragraph (2).

(4) The Commissioner of the Korea Disease Control and Prevention Agency shall notify the applicant of whether permission is to be granted within 60 days from the date of receiving the application for permission referred to in paragraph (3). In such cases, when granting permission, the Minister of Health and Welfare shall issue a permit to establish and operate the high-risk pathogen handling facility prescribed by Decree of the Ministry of Health and Welfare. <Amended on Sep. 11, 2020>

Article 19-3(Permission for changes to high-risk pathogens handling facilities) #

(1) Any person who intends to obtain permission for changes pursuant to the main clause of Article 23(3) of the Act shall submit a written application for permission for changes prescribed by Decree of the Ministry of Health and Welfare, along with documents certifying the grounds and details of the relevant changes of permitted matters, to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(2) The Commissioner of the Korea Disease Control and Prevention Agency shall notify the applicant of whether permission for changes is to be granted within 60 days from the date of receiving the application for permission for changes referred to in paragraph (1). In such cases, when granting permission for changes, the Commissioner of the Korea Disease Control and Prevention Agency shall issue a permit for changes prescribed by Decree of the Ministry of Health and Welfare. <Amended on Sep. 11, 2020>

(3) "Minor matters prescribed by Presidential Decree" in the proviso of Article 23(3) of the Act means any of the following:

1. The name, address and contact information of a person who establishes and operates the high-risk pathogen handling facility (limited to natural persons);

2. The name, address and contact information of a person who establishes and operates the high-risk pathogen handling facility (limited to corporations), and the name and contact information of the representative thereof;

3. The name and address of a person responsible for establishing and operating the high-risk pathogen handling facility referred to in Article 19-6(1)1, a manager in the exclusive charge of high-risk pathogens, and a person responsible for biological safety control.

(4) Any person who intends to report changes pursuant to the proviso of Article 23(3) of the Act shall submit a report on changes of permitted matters prescribed by Decree of the Ministry of Health and Welfare to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(5) Upon receipt of a report on changes of permitted matters under paragraph (4), the Commissioner of the Korea Disease Control and Prevention Agency shall issue a certificate of report on changes prescribed by Decree of the Ministry of Health and Welfare. <Amended on Sep. 11, 2020>

[This Article Added on Jun. 12, 2018]

Article 19-4(Report on changes to high-risk pathogen handling facilities) #

(1) Any person who intends to report changes pursuant to Article 23(4) of the Act shall submit a report on changes prescribed by Decree of the Ministry of Health and Welfare to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(2) The Commissioner of the Korea Disease Control and Prevention Agency shall notify the applicant of whether the report on changes filed under paragraph (1) is to be accepted, within 60 days from receipt of the report on changes. In such cases, if the report is to be accepted, the Commissioner of the Korea Disease Control and Prevention Agency shall issue a certificate of report on changes prescribed by Decree of the Ministry of Health and Welfare. <Amended on Jun. 2, 2020; Sep. 11, 2020>

[This Article Added on Jun. 12, 2018]

Article 19-5(Report on closure of high-risk pathogen handling facilities) #

(1) Any person who intends to report the closure of a high-risk pathogen handling facility pursuant to Article 23(5) of the Act shall submit a closure report prescribed by Decree of the Ministry of Health and Welfare, along with documents certifying the disposal of high-risk pathogens, to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

(2) The Commissioner of the Korea Disease Control and Prevention Agency shall notify the reporter of whether his or her report is to be accepted within 10 days from the date of receiving the closure report referred to in paragraph (1). In such cases, when accepting the report, the Minister of Health and Welfare shall issue a certificate of the closure report prescribed by Decree of the Ministry of Health and Welfare. <Amended on Sep. 11, 2020>

(3) Where the high-risk pathogen handling facility is closed pursuant to Article 23(5) of the Act, the Commissioner of the Korea Disease Control and Prevention Agency shall determine and publicly notify the methods, procedures, etc. for closing the high-risk pathogen handling facility, such as disinfecting high-risk pathogen handling facilities and disposing of high-risk pathogens. <Amended on Sep. 11, 2020>

[This Article Added on Jun. 12, 2018]

Article 19-6(Safety control guidelines regarding establishment and operation of high-risk pathogen handling facilities) #

(1) "Safety control guidelines prescribed by Presidential Decree" in Article 23(7) of the Act means the following: <Amended on Apr. 2, 2020; Jun. 2, 2020>

1. There shall be a person responsible for establishing and operating a high-risk pathogen handling facility, a manager in the exclusive charge of high-risk pathogens, and a person responsible for biological safety control;

2. He or she shall establish and operate a deliberative body composed of external experts, persons responsible for biological safety control, etc. at a high-risk pathogen handling facility in order to deliberate on matters related to safety control concerning the inspection, possession, management, and transport of high-risk pathogens;

3. Any high-risk pathogen shall be stored in a storage unit container indicating the relevant information, such as the name of high-risk pathogen, identification number including control number, and the date of manufacture, which shall be kept in a separate storage box or storage equipment with a locking device;

4. He or she shall operate a security system to control access to any area for handling or storing high-risk pathogens and to check the handling of high-risk pathogens;

5. Where He or she intends to use any high-risk pathogen after inactivating it (referring to treatment that permanently prevents its survival without disposing of it), he or she shall undergo deliberation by the deliberative body referred to in subparagraph 2;

6. He or she shall comply with the standards for granting permission and accepting reports prescribed in Article 19-2(2).

(2) Except as provided in paragraph (1), the details of safety control and matters pertaining to the composition, operation, etc. of the deliberative body referred to in paragraph (1)2 shall be determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

[This Article Added on Jun. 12, 2018]

Article 19-7(Supplement of documents submitted for permission for or report on high-risk pathogen handling facilities) #

The Commissioner of the Korea Disease Control and Prevention Agency may require the submission of additional documents within a period not exceeding 30 days, if deemed necessary for the supplementation of documents submitted for any of the following permission or reports; in such cases, the period required for supplementation shall not be included in the period for making decisions under Article 19-2(4) and (6), Article 19-3(2), and Article 19-5(2). <Amended on Sep. 11, 2020; Jun. 2, 2025>

1. Authorization or report on the installation and operation of high-risk pathogen handling facilities under Article 19-2;

2. Permission for changes to, and report on changes to, matters permitted concerning the installation and operation of high-risk pathogen handling facilities under Article 19-3;

3. Report on changes to high-risk pathogen handling facilities under Article 19-4;

4. Report on the closure of high-risk pathogen handling facilities under Article 19-5.

[This Article Added on Jun. 12, 2018]

Article 19-8(Matters requiring follow-up permission for possessing infectious pathogens spread through bioterrorism) #

"Unavoidable cause prescribed by Presidential Decree" in the proviso of Article 23-3(1) of the Act means any of the following cases where there is no intention to separate infectious pathogens spread through bioterrorism (hereinafter referred to as "infectious pathogens spread through bioterrorism") referred to in the main clause of that paragraph:

1. Where the infectious pathogens spread through bioterrorism are separated in the process of diagnosing diseases of patients of an infectious disease, etc. and is possessed;

2. Where the infectious pathogens spread through bioterrorism are separated in the process of diagnosing diseases of animals or plants and is possessed;

3. Where the infectious pathogens spread through bioterrorism are separated from environmental specimens such as food or soil and is possessed.

[This Article Added on Jun. 2, 2020]

Article 19-9(Matters for report on changes of permission for possessing infectious pathogens spread through bioterrorism) #

"Minor matter prescribed by Presidential Decree" in the proviso of Article 23-3(3) of the Act means the following:

1. The name, address and contact information of a person (limited to natural persons) who obtains permission for possessing pathogens of infectious disease spread through bioterrorism;

2. The name, address and contact information of a person (limited to legal persons) who obtains permission for possessing pathogens of infectious disease spread through bioterrorism and the name and contact information of the representative thereof;

3. The name, position and contact information of the manager who takes exclusive charge of high-risk pathogens.

[This Article Added on Jun. 2, 2020]

Article 20(Entrustment of vaccination services) #

(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor (excluding the Governor of a Self-Governing Province which has a local government Si or Gun under its jurisdiction; hereinafter the same shall apply) or the head of a Si/Gun/Gu may entrust vaccination services that are beyond the capability of public health centers or for residents, etc. having difficulty visiting public health centers under Article 24(2) and 25(2) of the Act, to medical institutions designated by the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the Si/Gun/Gu, from among the following medical institutions. In such cases, the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the Si/Gun/Gu shall publicly announce the institutions so entrusted. <Amended on Aug. 3, 2021; Aug. 18, 2023>

1. A medical clinic referred to in Article 3(2)1a of the Medical Service Act;

2. A hospital-level medical institution referred to in Article 3(2)3 of the Medical Service Act (in cases of dental hospitals or oriental medical hospitals, limited to those that have additionally established and operate a specialized department for medicine by hiring a physician pursuant to Article 43(2) of that Act).

(2) When entrusting vaccination services under paragraph (1), a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall prepare an entrustment contract providing for each of the following: <Added on Jan. 6, 2015; Aug. 18, 2023>

1. The scope of the vaccination services entrusted;

2. The period for the entrustment contract;

3. The terms and conditions of the entrustment contract;

4. The cancellation of the entrustment contract.

(3) Matters necessary for the procedures, etc. for calculation and reimbursement of vaccination expenses incurred in vaccination services entrusted under paragraph (1) shall be determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Jan. 6, 2015; Sep. 11, 2020>

Article 20-2(Pre-checking of vaccination records) #

The director of each public health center that provides vaccination services under Article 24(1) and 25(1) of the Act and the head of each medical institution entrusted with vaccination services under Article 24(2) (including where the said Article applies mutatis mutandis in Article 25(2) of the Act) of the Act (hereinafter referred to as the "director of each public health center, etc.") shall obtain written consent from those who intend to be vaccinated or from their legal representatives on the following matters under the main clause of Article 26-2(1) of the Act:

1. The fact that they have confirmed the details of the vaccination;

2. The method of confirming the details of the vaccination.

[This Article Added on Jun. 28, 2016]

Article 21(Organization of vaccination injury investigation teams) #

(1) The vaccination injury investigation team under Article 30(1) of the Act (hereafter in this Article referred to as the "injury investigation team") may be established in 2 or more units, if necessary, taking into account the number of cases of adverse reactions following vaccination against infectious diseases. <Added on Aug. 3 2021; Sep. 16 2025>

(2) An injury investigation team shall be comprised of not more than 10 members. <Amended on Aug. 3, 2021>

(3) The members of an injury investigation team shall be appointed or commissioned by the Commissioner of the Korea Disease Control and Prevention Agency from among public officials under his or her control or any of the following persons: <Amended on Sep. 11, 2020; Aug. 3, 2021>

1. Experts in the field of vaccination and adverse reactions to vaccinations;

2. Medical personnel defined in Article 2(1) of the Medical Service Act.

(4) An injury investigation team shall investigate the following matters and report the findings of investigation to the advisory committee on vaccination injury compensation: <Amended on Aug. 3, 2021>

1. The evaluation and supplementation of the findings of a basic investigation submitted by a Mayor/Do Governor under Article 31(2);

2. The intention or negligence on the part of a third party provided for in Article 72(1) of the Act;

3. Other matters determined by the advisory committee on vaccination injury compensation in relation to vaccination injury compensation.

(5) An injury investigation team member who conducts an injury investigation under paragraph (4) shall carry a certificate of vaccination injury investigator prescribed by Decree of the Ministry of Health and Welfare, and present it to relevant persons. <Amended on Aug. 3, 2021>

(6) The Commissioner of the Korea Disease Control and Prevention Agency may pay allowances and travel expenses incurred in conducting injury investigations to injury investigation team members, within the budget. <Amended on Sep. 11, 2020; Aug. 3, 2021>

(7) Detailed matters regarding the operation of an injury investigation team shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency, following a resolution by the advisory committee on vaccination injury compensation. <Amended on Sep. 11, 2020; Aug. 3, 2021>

Article 21-2(Persons eligible for subsidies for vaccination leave) #

(1) For subsidization of paid leave under Article 32-2(1) of the Act and subsidization of unused paid leave under paragraph (2) of that Article, all of the following requirements shall be satisfied:

1. A crisis alert of a serious level under Article 38(2) of the Framework Act on the Management of Disasters and Safety has been issued in response to the prevalence of any Class 1 infectious disease;

2. An employer under paragraph (2) has granted paid leave to his or her employee who received special vaccination pursuant to Article 25 of the Act, or a person falling under paragraph (3) has not taken paid leave after receiving special vaccination under Article 25 of the Act.

(2) An employer employing not more than four regular employees shall be subsidized under the latter part of Article 32-2(1) of the Act.

(3) Any of the following persons shall be subsidized under Article 32-2(2) of the Act:

1. Among artists under subparagraph 1a of Article 2 of the Employment Insurance Act, a person who has been subsidized for employment insurance premiums under Article 21 of the Act on Employment and Industrial Accident Premium Collection applied mutatis mutandis pursuant to Article 48-2(8)3 of the Act on the Collection of Insurance Premiums for Employment Insurance and Industrial Accident Compensation Insurance (hereinafter referred to as the "Act on Employment and Industrial Accident Premium Collection");

2. Among workers under subparagraph 1a of Article 2 of the Employment Insurance Act, a person who has been subsidized for employment insurance premiums under Article 21 of the Act on Employment and Industrial Accident Premium Collection applied mutatis mutandis pursuant to Article 48-3(8)3 of that Act.

(4) The scope of subsidization of paid leave under paragraph (2) and the scope of subsidization of unused paid leave under paragraph (3) shall be limited to cover expenses for one day of paid leave; provided, no subsidy shall be provided, where the day following the vaccination day is neither a working day nor a labor-providing day.

(5) The standard amount of subsidies shall be publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency after consultation with the Minister of Planning and Budget. <Amended on Dec. 30, 2025>

[This Article Added on Aug. 18, 2023]

[(previous) Article 21-2 moved to Article 21-4 <Aug. 18, 2023>]

Article 21-3(Procedures for subsidization of vaccination leave) #

(1) An employer who intends to be subsidized under the latter part of Article 32-2(1) of the Act shall submit a written application prescribed by Decree of the Ministry of Health and Welfare (including an application in electronic form) to a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, along with the following documents (including documents in electronic form):

1. A document verifying that the relevant employee was vaccinated and that the day following the date of vaccination was a working day;

2. A document evidencing that the relevant employee remains employed on the day following vaccination;

3. A document evidencing the grant of paid leave to the relevant employee;

4. Other documents deemed necessary by the Commissioner of the Korea Disease Control and Prevention Agency for subsidization of paid leave.

(2) An artist or a worker who intends to be subsidized under Article 32-2(2) of the Act shall submit a written application prescribed by Decree of the Ministry of Health and Welfare (including an application in electronic form) to a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, along with the following documents (including documents in electronic form):

1. A document verifying that the relevant artist or worker was vaccinated and that the day following vaccination was the day of providing labor;

2. Any of the following documents:

a. A document verifying that the relevant artist has been subsidized for employment insurance premiums under Article 21 of the Act on Employment and Industrial Accident Premium Collection applied mutatis mutandis pursuant to Article 48-2(8)3 of that Act;

b. A document verifying that the relevant worker has been subsidized for employment insurance premiums under Article 21 of the Act on Employment and Industrial Accident Premium Collection applied mutatis mutandis pursuant to Article 48-3(8)3 of that Act;

3. Other documents deemed necessary by the Commissioner of the Korea Disease Control and Prevention Agency for subsidization of non-use of paid leave.

(3) Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu receives a written application under paragraph (1), he or she shall verify the business registration certificate (referring to the business registration certificate with his or her resident registration number omitted; hereinafter the same shall apply) through administrative data matching under Article 36(1) of the Electronic Government Act; provided, any employer who does not give consent thereto shall be required to attach the relevant documents. <Amended on Apr. 23, 2024>

Article 21-4(Personal information of persons eligible for vaccination) #

(1) The personal information details of those eligible for vaccination, which the Commissioner of the Korea Disease Control and Prevention Agency may request from the relevant institutions and organizations under Article 33-4(2)1 of the Act, shall be as follows: <Amended on Jun. 12, 2018; Jun. 2, 2020; Sep. 11, 2020; Aug. 3, 2021>

1. Where a person eligible for vaccination is a national: The following materials:

a. The name, resident registration number, address, and phone number (including mobile phone number) of a person eligible for vaccination;

b. The following details on to which a person eligible for vaccination belongs:

1) Details of the school prescribed in Article 2 of the Elementary and Secondary Education Act, to which a person eligible for vaccination belongs;

2) Details of the kindergarten prescribed in subparagraph 2 of Article 2 of the Early Childhood Education Act to which a person eligible for vaccination belongs;

3) Details of the child care center prescribed in subparagraph 3 of Article 2 of the Infant Care Act to which a person eligible for vaccination belongs;

4) Details of the child welfare facility prescribed in subparagraph 10 of Article 3 of the Child Welfare Act to which a person eligible for vaccination belongs;

c. The following details of a person eligible for vaccination:

1) Whether a person eligible for vaccination is a person with disabilities registered pursuant to Article 32 of the Act on Welfare of Persons with Disabilities;

2) Whether a person eligible for vaccination is a member of a multicultural family prescribed in subparagraph 1 of Article 2 of the Multicultural Families Support Act;

3) Whether a person eligible for vaccination is a recipient prescribed in subparagraph 2 of Article 2 of the National Basic Living Security Act (including persons of the second lowest income bracket prescribed in subparagraph 10 of that Article) or a child of such recipient;

2. Where a person eligible for vaccination is a foreigner or a foreign nationality Korean: The following materials:

a. Information on the registration of aliens prescribed in Article 31 of the Immigration Act;

b. Information on reporting on the place of residence in Korea of a foreign nationality Korean prescribed in Article 6 of the Act on the Immigration and Legal Status of Overseas Koreans;

Article 21-5(Input of vaccination information) #

Where the director of a public health center, etc. provides a vaccination service, he or she shall, without delay, input the following information into the Integrated Vaccination Management System prescribed in Article 33-4(1) of the Act (hereinafter referred to as the "integrated management system") pursuant to Article 33-4(3) of the Act: <Amended on Jun. 2, 2020>

1. The following information on persons vaccinated:

a. Name;

b. Resident registration number; provided, where the person vaccinated is a foreigner or a foreign nationality Korean, it refers to the foreigner registration number or the domestic residence report number;

2. The following information on the details of vaccination:

a. Name of vaccination;

b. Number of vaccination;

c. Date/month/year of vaccination;

d. Name of the vaccine used in vaccination;

e. Names of the physician who made a preliminary diagnosis and the physician who vaccinated.

[This Article Added on Jun. 28, 2016]

[Moved from Article 21-3 <Aug. 18, 2023>]

Article 21-6(Provision of details of vaccination) #

(1) If the Commissioner of the Korea Disease Control and Prevention Agency provides the parents of children eligible for vaccination with the details of vaccination under the former part of Article 33-4(4) of the Act, he or she shall do so by means of perusal through the integrated management system; provided, where the Commissioner of the Korea Disease Control and Prevention Agency deems it necessary, such details may be provided by text message, email, telephone, mail, or other methods equivalent thereto. <Amended on Jun. 2, 2020; Sep. 11, 2020; Sep. 16, 2025>

(2) Where the Commissioner of the Korea Disease Control and Prevention Agency issues a certificate of vaccination under the former part of Article 33-4(4) of the Act, he or she may issue such certificate directly through the integrated management system as prescribed by the Commissioner of the Korea Disease Control and Prevention Agency, or issue such certificate in connection with an electronic civil petition window referred to in Article 12-2(3) of the Civil Petitions Treatment Act. <Amended on Jun. 2, 2020; Sep. 11, 2020; Jul. 11, 2022>

[This Article Added on Jun. 28, 2016]

[Moved from Article 21-4 <Aug. 18, 2023>]

Article 22(Procedures for formulating crisis control measures against infectious diseases) #

(1) The Minister of Health and Welfare and the Commissioner of the Korea Disease Control and Prevention Agency may request relevant administrative agencies, local governments, or public institutions, etc. prescribed in Article 4 of the Act on the Management of Public Institutions to submit materials, in order to formulate crisis control measures against infectious diseases under Article 34(1) of the Act. <Amended on Sep. 11, 2020>

(2) The Minister of Health and Welfare and the Commissioner of the Korea Disease Control and Prevention Agency shall notify the heads of the relevant central administrative agencies of the crisis control measures against infectious diseases formulated under Article 34(1) of the Act. <Amended on Sep. 11, 2020>

Article 22-2(Information excluded from disclosure during infectious disease emergencies) #

(1) "Information prescribed by Presidential Decree" in Article 34-2(1) of the Act means the following information:

1. Name;

2. Address of a domicile of an Eup/Myeon/Dong or lower level of district;

3. Other information determined by the Commissioner of the Korea Disease Control and Prevention Agency as unrelated to the prevention of infectious diseases, taking into consideration the characteristics of each infectious disease.

(2) Where the Commissioner of the Korea Disease Control and Prevention Agency has determined information not related to the prevention of infectious diseases pursuant to paragraph (1)3, he or she shall publish the details of such unrelated information on the website of the Korea Disease Control and Prevention Agency and inform the Mayor/Do Governor and the head of a Si/Gun/Gu thereof.

[This Article Added on Dec. 29, 2020]

Article 22-3(Integrated infectious disease control information system) #

(1) "Personally identifiable information defined in Article 24 of the Personal Information Protection Act and other personal information prescribed by Presidential Decree" in Article 40-5(2)1 of the Act means the information classified as follows:

1. Where patients of an infectious disease, etc. are nationals of the Republic of Korea: Name, resident registration number, address, occupation, and contact information;

2. Where patients of an infectious disease, etc. are foreigners: Matters to be registered by aliens and contact information under each subparagraph of Article 32 of the Immigration Act;

3. Where patients of an infectious disease, etc. are foreign national Koreans: Matters for report of a domestic place of residence and contact information under each subparagraph of Article 7(1) of the Enforcement Decree of the Act on the Immigration and Legal Status of Overseas Koreans.

(2) "Data prescribed by Presidential Decree" in Article 40-5(2)2 of the Act means the following data:

1. Data collected through reporting and notification under Articles 11 through 14 of the Act;

2. Data regarding the sentinel surveillance of infectious diseases under the former part of Article 16(2) of the Act;

3. Information about the results of epidemiological investigations conducted under the main clause of Article 18(1) of the Act;

4. Information on patients of an infectious disease, etc. and persons suspected of contracting an infectious disease, which is collected under Article 76-2(1) and (2) of the Act;

5. Data regarding the current status of the following medical resources in each medical institution:

a. Medical personnel defined in Article 2(1) of the Medical Service Act;

b. Drugs under subparagraph 4 of Article 2 of the Pharmaceutical Affairs Act;

c. Medical facilities, equipment, and products;

6. Other data determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, which are necessary for prevention, control, and treatment of patients of an infectious disease, etc.

(3) "Information system prescribed by Presidential Decree" in Article 40-5(3)7 of the Act means any of the following information systems: <Amended on Jun. 27 2023; Sep. 16 2025>

Article 23(Methods and procedures for treatment and quarantine or isolation) #

Methods, procedures, etc. for hospital treatment, self-treatment, and facility treatment under Article 41(1) and (2) of the Act, and for home quarantine or institutional quarantine or isolation under Article 42(2) of the Act shall be as specified in Appendix 2. <Amended on Jun. 2, 2020; Oct. 13; 2020>

[Title Amended on Jun. 2, 2020]

Article 23-2(Methods of and procedures for transfer) #

(1) Where the head of an infectious disease control institution, etc. prescribed in Article 41(1) of the Act (hereinafter referred to as "infectious disease control institution, etc."), the head of a medical institution which is not an infectious disease control institution, etc., or the head of a facility established and operated pursuant to Article 37(1)2 of the Act (hereafter referred to as "facility" in this Article) falls under any subparagraph of Article 41(3) of the Act, he or she may request the competent Special Self-Governing City Mayor, the competent Special Self-Governing Province Governor and the head of the competent Si/Gun/Gu to take measures, such as transfer or relocation of persons receiving medical treatment at the relevant institutions under paragraph (1) or (2) of that Article to another medical institution or facility under paragraph (3) of that Article (hereinafter referred to "transfer, etc."). <Amended on Aug. 18, 2023>

(2) Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu falls in any of the following cases, he or she may take measures of transfer, etc. within his or her jurisdiction: <Amended on Aug. 18, 2023>

1. If the person has received a request for transfer, etc. pursuant to paragraph (1);

2. Cases falling under any subparagraph of Article 41(3) of the Act, where it is deemed necessary to take measures of transfer, etc. of a person who is undergoing self-treatment within the jurisdiction.

(3) Where it is difficult to take measures of transfer, etc. pursuant to paragraph (2) due to the shortage of isolation beds and facilities within the jurisdiction, the head of a Si/Gun/Gu may request the Mayor/Do Governor having jurisdiction over the relevant Si/Gun/Gu to take measures of transfer, etc.

(4) Where a Mayor/Do Governor is requested to take measures of transfer, etc. pursuant to paragraph (3), he or she may take measures of transfer, etc. among Sis/Guns/Gus within the jurisdiction.

(5) The head of an infectious disease control institution, etc., the head of a medical institution which is not an infectious disease control institution, etc., the head of a facility, or the Mayor/Do Governor may request the Minister of Health and Welfare or the Commissioner of the Korea Disease Control and Prevention Agency to take measures of transfer, etc. in accordance with the following classification: <Amended on Dec. 29, 2020>

1. The head of an infectious disease control institution, etc., the head of a medical institution which is not an infectious disease control institution, etc., or the head of a facility: Where measures of transfer, etc. between Cities/Dos are urgently needed, notwithstanding paragraph (1);

Article 23-3(Providing subsidies for paid leave) #

(1) Subsidies for paid leave provided to employers under Article 41-2(3) of the Act shall be in the amount calculated by multiplying the amount publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Planning and Budget by the period during which an employee is hospitalized or quarantined or isolated under the Act. <Amended on Sep. 11, 2020; Dec. 30, 2025>

(2) An employer who intends to be subsidized under Article 41-2(3) of the Act shall submit a written application (including a written application in electronic document) prescribed by Decree of the Ministry of Health and Welfare to the Commissioner of the Korea Disease Control and Prevention Agency along with the following documents (including electronic documents): <Amended on Sep. 11, 2020>

1. Documents verifying the fact that an employee is hospitalized, quarantined, or isolated and the period of such hospitalization or quarantine or isolation;

2. Documents evidencing that an employee continues to hold office, such as a certificate of employment;

3. Documents evidencing that the employer has given a paid leave to the relevant employee, such as a pay slip;

4. Other documents deemed particularly necessary by the Commissioner of the Korea Disease Control and Prevention Agency to provide subsidies for paid leave.

(3) Where the Commissioner of the Korea Disease Control and Prevention Agency receives a written application under paragraph (2), he or she shall verify the business registration certificate through administrative data matching under Article 36(1) of the Electronic Government Act; provided, where the relevant employer who does not give consent thereto shall be required to attach the relevant documents. <Amended on Sep. 11, 2020; Apr. 23, 2024>

(4) Where the Commissioner of the Korea Disease Control and Prevention Agency receives a written application under paragraph (2), he or she shall determine whether to grant subsidies for paid leave and the amount of subsidies, and inform the relevant employer thereof in writing. <Amended on Sep. 11, 2020>

(5) Except as provided in paragraphs (2) through (4), matters necessary for the procedures for applying for subsidies for paid leave, notification of the results thereof, etc. shall be prescribed by Decree of the Ministry of Health and Welfare.

[This Article Added on Jun. 28, 2016]

Article 23-4(Designation of infectious disease control institutions for quarantine or isolation of patients of infectious diseases) #

(1) An institution eligible to be designated as an infectious disease control institution to conduct an examination, diagnosis, or quarantine or isolation, treatment, etc. of patients of infectious diseases, etc. under Article 42(4) and (7) of the Act shall be an infectious disease control institution designated under Article 36(1) and (2) of the Act (hereinafter referred to as "infectious disease control institution") having single-occupancy hospital rooms (referring to hospital rooms with anterooms and negative pressure facilities) for patients of infectious diseases, etc. <Amended on Apr. 2, 2020; Jun. 2, 2020>

(2) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu designates an infectious disease control institution for conducting examination, medical diagnosis, quarantine or isolation, and treatment under Article 42(11) of the Act, he or she shall consider the findings of evaluation of infectious disease control facilities prescribed in Article 39-2 of the Act. <Amended on Apr. 2, 2020; Sep. 11, 2020>

(3) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu designates an infectious disease control institution for conducting examination, medical diagnosis, quarantine or isolation, and treatment under Article 42(11) of the Act, he or she shall issue a certificate of designation, as prescribed by the Minister of Health and Welfare. <Amended on Apr. 2, 2020; Sep. 11, 2020>

[This Article Added on Jun. 28, 2016]

[Moved from Article 23-3 <Oct. 13, 2020>]

Article 24(Facilities requiring disinfection) #

Facilities that require disinfection necessary for preventing infectious diseases under Article 51(3) of the Act shall be as follows: <Amended on Dec. 8, 2011; Jul. 7, 2014; Jan. 6, 2015; Jan. 19, 2016; Jun. 28, 2016; Aug. 11, 2016; Mar. 29, 2017; Jun. 2, 2020; Jun. 8, 2021; Nov. 29, 2022>

1. Lodging establishments (limited to those with at least 20 guest rooms) specified in the Public Health Control Act and tourist accommodation establishments specified in the Tourism Promotion Act;

2. Food service business places (hereinafter referred to as "food service establishments") with a total floor area of at least 300 square meters specified in subparagraph 8 (excluding item e thereof) of Article 21 of the Enforcement Decree of the Food Sanitation Act;

3. Intra-city buses, rural buses, shuttle buses, cross-country buses, chartered buses, and funeral coaches specified in the Passenger Transport Service Act; aircraft specified in the Aviation Safety Act and airport facilities specified in the Airport Facilities Act; passenger ships specified in the Marine Transportation Act; waiting lounges with a total floor area of at least 300 square meters specified in the Harbor Act; and rolling stock for passenger transportation, stations, and station facilities specified in the Railroad Service Act and the Urban Railroad Act;

4. Superstores, specialty stores, department stores, shopping centers, multiplex shopping malls, and other large-scale stores specified in the Distribution Industry Development Act, and traditional markets specified in the Special Act on the Development of Traditional Markets and Shopping Districts;

5. Hospital-level medical institutions prescribed in Article 3(2)3 of the Medical Service Act;

6. Meal service facilities (limited to those capable of providing meals continuously for at least 100 persons simultaneously) specified in subparagraph 12 of Article 2 of the Food Sanitation Act;

6-2. Food service establishments engaged in catering service business, with a total floor area of at least 300 square meters, specified in subparagraph 8e of Article 21 of the Enforcement Decree of the Food Sanitation Act;

7. Dormitories specified in subparagraph 2d of Appendix 1 attached to the Enforcement Decree of the Building Act;

7-2. Boarding houses (limited to those with accommodation capacity of at least 50 persons) specified in subparagraph 8a of Appendix 2 of the Enforcement Decree of the Act on Installation and Management of Firefighting Systems;

Article 25(Eligibility to become disease control officers and duties) #

(1) Disease control officers specified in Article 60(1) of the Act shall be appointed from among public officials of at least Grade IV with substantial experience in a field related to infectious diseases; provided, disease control officers of each Si/Gun/Gu may be appointed, from among public officials of at least Grade V with substantial experience in a field related to infectious diseases. <Amended on Jan. 6, 2016>

(2) In addition to the authority to take measures specified in Article 60(3) of the Act, each disease control officer shall have the authority to take the following measures in the outbreak area of an infectious disease: <Amended on Jan. 6, 2016; Jun. 2, 2020>

1. Hospitalizing or quarantining persons suspected of contracting an infectious disease for a certain period at an appropriate place;

2. Disinfecting places or buildings contaminated by the infectious pathogens, or taking other necessary measures;

3. Issuing orders to prohibit laundering at certain places or to handle wastes at designated places;

4. Taking measures to prevent zoonoses, against persons who have involved in slaughter or persons, etc. exposed to zoonoses.

(3) Deleted. <Jan. 6, 2016>

Article 26(Duties of epidemiological investigation officers and epidemiological investigation officer trainees) #

(1) Deleted. <Jan. 6, 2016>

(2) Epidemiological investigation officers and epidemiological investigation officer trainees shall perform the following duties: <Amended on Aug. 18, 2023>

1. Formulating epidemiological investigation plans;

2. Conducting, and analyzing the findings of, epidemiological investigations;

3. Developing the criteria and methods for conducting epidemiological investigations;

4. Providing technical guidance on epidemiological investigations;

5. Providing education and training on epidemiological investigations;

6. Conducting epidemiological research on infectious diseases.

(3) Deleted. <Jan. 6, 2016>

(4) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, and the head of a Si/Gun/Gu may pay research expenses and travel expenses to epidemiological investigation officers and epidemiological investigation officer trainees, within the budget. <Amended on Sep. 11, 2020; Oct. 13, 2020; Aug. 18, 2023>

[Title Amended on Aug. 18, 2023]

Article 26-2(Ordering medical personnel to engage in disease control duties) #

(1) When issuing an order to engage in disease control duties under Article 60-3(1) of the Act, the Commissioner of the Korea Disease Control and Prevention Agency, the Mayor/Do Governor, or the head of a Si/Gun/Gu shall issue a written order to engage in disease control duties. In such cases, the written order shall include the institution of duty, period of engagement, and assigned duties. <Amended on Sep. 11, 2020; Jun. 2, 2025>

(2) The period of engagement in disease control duties under Article 60-3(1) of the Act shall not exceed 30 days; provided, a different period may be set if the person gives prior written consent.

(3) If the Commissioner of the Korea Disease Control and Prevention Agency, the Mayor/Do Governor, or the head of a Si/Gun/Gu intends to extend the period of engagement under paragraph (2), he or she shall obtain the person's consent before the expiration of the relevant period. In such cases, the extension period shall not exceed 30 days, unless a different extension period is set with the person's consent. <Amended on Sep. 11, 2020; Jun. 2, 2025>

(4) If the Commissioner of the Korea Disease Control and Prevention Agency, the Mayor/Do Governor, or the head of a Si/Gun/Gu extends the period of engagement under paragraph (3), he or she shall issue a new written order to engage in disease control duties. <Amended on Sep. 11, 2020; Jun. 2, 2025>

[This Article Added on Jun. 28, 2016]

Article 26-3(Appointment of disease control officers) #

(1) Where the Commissioner of the Korea Disease Control and Prevention Agency, the Mayor/Do Governor, or the head of a Si/Gun/Gu appoints a disease control officer under Article 60-3(2) of the Act, he or she shall issue a certificate of appointment. In such cases, the relevant certificate of appointment shall include the period for conducting duties. <Amended on Jun. 2, 2020; Sep. 11, 2020; Dec. 29; 2020>

(2) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor or the head of a Si/Gun/Gu appoints an epidemiological investigation officer under Article 60-3(3) of the Act, he or she shall issue a certificate of appointment. In such cases, the relevant certificate of appointment shall include the period for conducting duties. <Added on Jun. 2, 2020; Sep. 11, 2020>

(3) Article 26-2(2) through (4) shall apply mutatis mutandis to periods for conducting duties, extension of periods for conducting duties, issuance of certificates of appointment following the extension of periods for conducting duties, etc. of disease control officers and epidemiological investigation officers. <Added on Jun. 2, 2020>

[This Article Added on Jun. 28, 2016]

Article 26-4(Operation of the Korea Advanced Center for Vaccine Development) #

(1) The head of the Korea Advanced Center for Vaccine Development (hereinafter referred to as the "Director of the Korea Advanced Center for Vaccine Development"), established under Article 63-2(1) of the Act (hereinafter referred to as the "Korea Advanced Center for Vaccine Development"), shall be appointed by the Commissioner of the Korea Disease Control and Prevention Agency, as prescribed by the articles of incorporation.

(2) The Director of the Korea Advanced Center for Vaccine Development shall submit to the Commissioner of the Korea Disease Control and Prevention Agency the business plan and the statement of revenues and expenditures for the following fiscal year, after obtaining a resolution of the board of directors, by the beginning of each fiscal year. The same shall apply where any changes are to be made thereto.

(3) Except as provided in paragraphs (1) and (2), matters necessary for the operation of the Korea Advanced Center for Vaccine Development shall be prescribed by the articles of incorporation.

[This Article Added on Jun. 2, 2025]

Article 26-5(Duties of the Korea Advanced Center for Vaccine Development) #

"Duties prescribed by Presidential Decree" in Article 63-3(1)4 of the Act means the following duties:

1. Duties to support the development of medicines and vaccines for infectious diseases using artificial intelligence;

2. Duties to support testing and analysis for the development of medicines and vaccines for infectious diseases.

[This Article Added on Jun. 2, 2025]

Article 27(Ratio of subsidy on part of Cities/Dos) #

Subsidies for expenses from a City/Do under Article 66 of the Act [excluding a Special Self-Governing City and a Special Self-Governing Province (referring to a Special Self-Governing Province which has no Si/Gun which is a local government within its jurisdiction)] shall be 2/3 of the amount to be borne by a Si/Gun/Gu. <Amended on Aug. 18, 2023; Sep. 26, 2023>

Article 28(Objects and scope of compensation for loss) #

(1) Objects and scope of compensation for loss prescribed in Article 70(1) of the Act are as prescribed in Appendix 2-2.

(2) If necessary to calculate the amount of compensation for loss under Article 70(1) of the Act, the Compensation Deliberation Committee prescribed in Article 70-2(1) of the Act (hereinafter referred to as the "Deliberation Committee") may have specialized institutions or experts in the relevant areas appraise, evaluate, investigate, etc. the subject-matter of the loss.

(3) Where the Deliberation Committee calculates compensation for the loss in Article 70(1)1 through 3 of the Act, it shall consider the annual average revenue, business profits, etc. of the relevant medical institution.

[This Article Wholly Amended on Jun. 28, 2016]

Article 28-2(Exclusion from payment and standards for reducing compensation for loss) #

(1) The types of misconduct for which compensation for the loss shall not be paid or shall be reduced for violating the duty to take measures prescribed by this Act or by the relevant statutes or regulations, under Article 70(3) of the Act, shall be as follows: <Amended on Dec. 29, 2020>

1. Neglecting or interfering with reporting prescribed in Article 11 of the Act or making such report falsely;

2. Neglecting the obligation to report prescribed in Article 12 of the Act or interference with reporting of persons obligated to report prescribed in the subparagraphs of paragraph (1) of that Article;

3. Engaging in misconduct in conducting an epidemiological investigation prescribed in Article 18(3) of the Act;

4. Failure in installing infectious disease control facilities prescribed in Article 36(3) or 37(2) of the Act;

5. Violating the duty to render cooperation prescribed in Article 60(4) of the Act;

6. Violating directions and orders prescribed in Article 59(1) of the Medical Service Act;

7. Violating the duties to make measures the Minister of Health and Welfare publicly notifies in recognition that such duties are particularly important among statutory duties to take measures.

(2) If compensation for loss is not paid or curtailed under Article 70(3) of the Act, such non-payment or curtailed amount shall be based on whether the misconduct in the subparagraphs of paragraph (1) is directly related to the occurrence or expansion of the loss and whether such misconduct is a major cause of the loss. <Amended on Sep. 16, 2025>

(3) Where the Deliberation Committee recognizes the existence of the causal relationship between the misconduct in the subparagraphs of paragraph (1) and the occurrence or expansion of loss under paragraph (2), it shall consider the motives for, details, nature, type, etc. of, the relevant misconduct comprehensively.

(4) The Minister of Health and Welfare shall determine and publicly notify detailed matters necessary for exclusion from payment, standards for payment in reduced amounts, etc. of compensation for loss prescribed in paragraphs (2) and (3).

[This Article Added on Jun. 28, 2016]

Article 28-3(Composition and operation of the Compensation Deliberation Committee) #

(1) Members of the Deliberation Committee established in the Ministry of Health and Welfare shall be appointed or commissioned by the Minister of Health and Welfare, from among the following persons duly considering gender:

1. Persons recommended by medical personnel organizations and medical institution organizations established under the Medical Service Act, and by the Korean Pharmaceutical Association and the Association of Korean Oriental Pharmacy established under the Pharmaceutical Affairs Act;

2. Persons recommended by organizations recognized by the Minister of Health and Welfare to be closely related to the field of health and medical services as non-profit, non-governmental organizations established under the Assistance for Non-Profit, Non-Governmental Organizations Act;

3. Persons recommended by the President of the National Health Insurance Service or by the President of the Health Insurance Review and Assessment Service under the National Health Insurance Act;

4. Persons holding office or have held office in the position of at least associate professor or in a position equivalent thereto at health and medical services-related departments of universities prescribed in the Higher Education Act;

5. Persons with considerable knowledge and experience in the prevention and control of infectious diseases;

6. Persons with considerable knowledge and experience in compensation for loss;

7. Members of the Senior Executive Service in charge of policies for health and medical services.

(2) The term of office of commissioned members prescribed in paragraph (1)1 through 6 shall be three years; provided, the term of office of members newly commissioned resulting from the dismissal, etc. of another member shall be their predecessor’s remaining term of office.

(3) Where a commissioned member of the Deliberation Committee under paragraph (1) falls under any of the following cases, the Minister of Health and Welfare may dismiss the relevant commissioned member:

1. Where a commissioned member of the Deliberation Committee becomes unable to perform his or her duties due to mental or physical disability;

2. Where a commissioned member of the Deliberation Committee engages in any misconduct in connection with his or her duties;

Article 28-4(Subsidization to health and medical services personnel) #

(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may subsidize expenses, such as allowances and travel expenses, to the medical personnel, founders of medical institutions, or pharmacists who have rendered assistance for the surveillance of outbreak, prevention and control, or epidemiological investigation of infectious diseases under Article 70-3(1) of the Act. <Amended on Sep. 11, 2020; Jun. 8, 2021>

(2) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may provide subsidies to cover expenses, such as allowances and travel expenses, to health and medical services personnel and the staff working in health and medical institutions who provide assistance to the surveillance of outbreak, and the prevention, quarantine, examination, treatment, control, and epidemiological investigation of infectious diseases pursuant to Article 70-3(2) of the Act. <Added on Mar. 22, 2022>

(3) A person who intends to receive subsidies under paragraph (1) or (2) shall file an application for subsidization with the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu, along with materials evidencing that he or she has rendered assistance for the surveillance of outbreak, and the prevention, quarantine, examination, treatment, control, and epidemiological investigation of infectious diseases. <Amended on Sep. 11, 2020; Mar. 22, 2022>

(4) Upon receipt of an application for subsidization under paragraph (3), the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall determine whether to grant subsidies, subsidy items, subsidy amount, etc. and inform the applicant of the details of determination. <Amended on Sep. 11, 2020; Mar. 22, 2022>

[This Article Added on Jun. 28, 2016]

[Title Amended on Mar. 22, 2022]

Article 28-5(Livelihood assistance for patients of infectious diseases) #

The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may provide the following subsidies under Article 70-4(1) of the Act; provided, no subsidies prescribed in subparagraph 2 shall be provided where paid leave is granted under Article 41-2(1) of the Act: <Amended on Sep. 11, 2020; Dec. 30, 2025>

1. Medical costs and hospitalization costs: The medical costs and hospitalization costs to be borne by the person in question; provided, costs prescribed by the Commissioner of the Korea Disease Control and Prevention Agency, such as costs excluded from costs eligible to be covered by medical care benefits prescribed by the National Health Insurance Act, shall be excluded;

2. Costs for supporting livelihood: The amount publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency after consulting with the Minister of Planning and Budget.

[This Article Added on Jun. 28, 2016]

Article 28-6(Persons eligible for psychological support) #

(1) The scope of on-site response personnel eligible for psychological support referred to in Article 15-2(1) of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients (hereinafter referred to as "psychological support") under Article 70-6(1) of the Act shall be as follows: <Amended on Aug. 18, 2023>

1. A medical practitioner and medical personnel who are mobilized during an epidemic period of an infectious disease pursuant to Article 49(1)12 of the Act;

2. Disease control officers appointed under Article 60(1) and 60-3(2) of the Act;

3. Epidemiological investigation officers and epidemiological investigation officer trainees under Article 60-2(1), (2) and (4) and 60-3(3) of the Act;

4. Other persons in charge of affairs concerning the prevention or control of infectious diseases, who are deemed by the Minister of Health and Welfare as necessary to receive psychological support.

(2) The Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may delegate or entrust his or her authority or duties regarding psychological support to the following institutions under Article 70-6(2) of the Act:

1. A mental health welfare center referred to in subparagraph 3 of Article 3 of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients;

2. A mental medical institution referred to in subparagraph 5 of Article 3 of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients;

3. The National center for Disaster and Trauma under Article 15-2 of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients;

4. Other institutions deemed by the Minister of Health and Welfare to have expertise in psychological support.

(3) Where the Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu delegates or entrusts his or her authority or duties regarding psychological support under paragraph (2), he or she shall publicly notify the following matters:

1. Institutions delegated or entrusted with authority or duties;

2. Details of delegated or entrusted authority or duties.

[This Article Added on Dec. 29, 2020]

Article 29(Standards for compensation for injuries caused by vaccinations) #

Standards for payment of compensation and deadline for application therefor under Article 71(1) of the Act shall be as follows: <Amended on Jan. 6, 2015; May 29, 2017; Sep. 18, 2018; Jul. 9, 2019; Jun. 2, 2020; Sep. 11, 2020>

1. Medical expenses:

a. Standards for payment: The balance of the medical expenses for a disease contracted by an injury resulting from vaccination, less the amount borne or paid by an insurer under the National Health Insurance Act, or less the amount borne by the medical care fund under the Medical Care Assistance Act; provided, when the lump-sum compensation is paid under subparagraph 3, no medical expenses shall be paid;

b. Deadline for application: within five years from the day the injury resulting from vaccination occurs;

2. Nursing expenses: 50,000 won per day only for inpatient treatment;

3. Lump-sum compensation for those who become disabled:

a. Standards for payment:

1) Persons with severe disabilities among the persons with disabilities prescribed in the Act on Welfare of Persons with Disabilities: 100/100 of the lump-sum compensation for death;

2) Persons with minor disabilities among the persons with disabilities prescribed in the Act on Welfare of Persons with Disabilities: 55/100 of the lump-sum compensation for death;

3) Persons with disabilities, other than persons with disabilities referred to 1) and 2) above, who fall under the grades of disability or grades of personal damage prescribed in the Acts determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, such as the National Pension Act, the Public Officials Pension Act, the Public Officials' Accident Compensation Act, and the Industrial Accident Compensation Insurance Act: An amount the Commissioner of the Korea Disease Control and Prevention Agency determines and publicly notifies by standard for the relevant grade of disability or personal damage within the scope of 20/100 of the lump-sum compensation for death;

b. Deadline for application: Within five years from the day of disability diagnosis;

4. Lump-sum compensation for a person who died:

a. Standards for payment: An amount equivalent to the monthly minimum wage prescribed under the Minimum Wage Act as at the time of death, multiplied by 240;

Article 30(Persons eligible for compensation for injuries caused by vaccination) #

(1) A person eligible for compensation under Article 71(1) of the Act shall be as follows:

1. For cases falling under Article 71(1)1 and 2 of the Act: Victims;

2. For cases falling under Article 71(1)3 of the Act: Bereaved family members determined based on the order of priority.

(2) "Bereaved family members ... prescribed by Presidential Decree" in Article 71(1)3 of the Act means the spouse (including a person in a de facto marital relationship), children, parents, grandsons and granddaughters, grandparents, and siblings.

(3) The priority order of bereaved family members shall coincide with the order listed in paragraph (2), excluding those to whom the compensation cannot be provided due to missing, etc.; and if at least two bereaved family members are in the same order of priority, the lump-sum compensation for death shall be apportioned equally among them.

Article 31(Compensation procedures for injuries caused by vaccination) #

(1) Any person who intends to receive compensation under Article 71(1) of the Act shall submit a written claim for compensation to the competent Special Self-Governing City Mayor, the competent Special Self-Governing Province Governor or the head of the competent Si/Gun/Gu, along with a document evidencing his or her injury, as prescribed by Decree of the Ministry of Health and Welfare. <Amended on Aug. 18, 2023>

(2) The head of a Si/Gun/Gu shall submit documents received under paragraph (1) (hereinafter referred to as "claim documents for injury compensation") to the competent Mayor/Do Governor; and the Mayor/Do Governor in receipt of the claim documents for injury compensation or the Special Self-Governing City Mayor or the Special Self-Governing Province Governor in receipt of the claim documents for injury compensation under paragraph (1) shall forward the claim documents for injury compensation without delay to the Commissioner of the Korea Disease Control and Prevention Agency, along with the findings of basic investigation conducted by him or her regarding the injury that has resulted from vaccination and the statement of his or her views thereon. <Amended on Sep. 11, 2020; Sep. 26, 2023>

(3) The Commissioner of the Korea Disease Control and Prevention Agency shall determine whether to provide compensation after gathering consensus from the advisory committee on vaccination injury compensation and notify the relevant Mayor/Do Governor of the determination, and the Mayor/Do Governor (excluding a Special Self-Governing City Mayor or a Special Self-Governing Province Governor) shall notify the head of the relevant Si/Gun/Gu thereof. In such cases, the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the Si/Gun/Gu so notified shall notify the relevant claimant for compensation under paragraph (1) of the details of the determination. <Amended on Jan. 6, 2015; Sep. 11, 2020; Aug. 18, 2023; Sep. 26, 2023>

(4) The Commissioner of the Korea Disease Control and Prevention Agency shall pay a person determined eligible for compensation under paragraph (3) the amount of compensation under the compensation standards under Article 29. <Amended on Sep. 11, 2020>

(5) Except as provided in this Decree, matters necessary for the procedures and methods for deliberation on compensation for injuries caused by vaccination shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020>

Article 32(Delegation of authority and entrustment of business affairs) #

(1) The Minister of Health and Welfare shall delegate the following authority to the Commissioner of the Korea Disease Control and Prevention Agency pursuant to Article 76(1) of the Act: <Amended on Sep. 11, 2020; Jul. 26, 2022; Sep. 30, 2025>

1. Operation of and support for the central infectious disease hospital under Article 8-2(1) and (3) of the Act and Article 1-3 of this Decree;

2. Operation of the medical resource information system under Article 8-2(4);

2. Formulation and implementation of measures for controlling resistant bacteria under Article 8-3 of the Act and Article 1-6 of this Decree;

4. Request for cooperation, such as hearing opinions or requesting the submission of data, under Article 8-4 of the Act.

(2) The Minister of Health and Welfare may entrust the duties prescribed in Article 70 of the Act to any of the following entities, pursuant to Article 76(1) of the Act: <Added on Jan. 6, 2015; Jan. 6, 2016; Jun. 2, 2020; Sep. 11, 2020; Oct. 13, 2020>

1. Schools defined in Article 2 of the Higher Education Act;

2. Public institutions under Article 4 of the Act on the Management of Public Institutions;

3. Non-profit corporations established under the Civil Act or other statutes to conduct affairs related to the prevention and control of infectious diseases;

4. A government-funded research institute established under the Act on the Establishment, Operation and Fostering of Government-Funded Research Institutes;

5. Other institutions or organizations deemed by the Minister of Health and Welfare to have expertise in the prevention and control of infectious diseases.

(3) Pursuant to Article 76(2) of the Act, the Commissioner of the Korea Disease Control and Prevention Agency shall delegate his or her authority to determine and pay compensation (limited to compensation with which medical expenses are payable in the amount not exceeding 300,000 won under Article 71(1)1 of the Act and subparagraph 1a of Article 29 of this Decree) under Article 71(2) and (3) of the Act and Article 31(3) and (4) of this Decree to the Mayor/Do Governor. <Added on Jan. 25, 2022>

(4) The duties that the Commissioner of the Korea Disease Control and Prevention Agency may entrust under Article 76(2) of the Act shall be as follows: <Added on Sep. 16 2025>

Article 32-2(Information requestable to be provided) #

(1) "Information prescribed by Presidential Decree" in Article 76-2(1)3 of the Act means the following information: <Added on Sep. 26, 2023>

1. Information on the severity of disability, types of disabilities, types of disabilities, income quintile, and places of business out of information on the insured and their dependents under Article 5 of the National Health Insurance Act;

2. Information on the severity of disability, type of disability, and income quintile out of information on eligible recipients under Article 3 of the Medical Care Assistance Act;

3. Other information equivalent to those referred to in subparagraph 1 or 2, which is determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency as necessary for the prevention and control of infectious diseases and the prevention of the spread of infection;

(2) "Information prescribed by Presidential Decree" in Article 76-2(1)4 of the Act means the following information: <Added on Sep. 26, 2023>

1. Medical treatment history, medication information, details of injuries and diseases, and information on health care institutions, out of information on claims for and payment of costs of health care benefits under Article 47 of the National Health Insurance Act;

2. Medical treatment history, medication information, details of injury and disease, and information on institutions providing medical benefits, out of information on claims for expenses for benefits under Article 11 of the Medical Benefit Act;

3. Other information equivalent to those referred to in subparagraph 1 or 2, which is determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency as necessary for the prevention and control of infectious diseases and the prevention of the spread of infection;

(3) "Information prescribed by Presidential Decree" in Article 76-2(1)6 of the Act means the following information: <Amended on Sep. 12, 2023; Sep. 26, 2023>

1. Credit card, debit card, and pre-paid card statements defined in subparagraphs 3,6, and 8 of Article 2 of the Specialized Credit Finance Business Act;

2. Transportation card statements specified in Article 10-2(1) of the Act on the Support and Promotion of Utilization of Mass Transit System;

3. Image data compiled through fixed visual data processing equipment defined in subparagraph 7 of Article 2 of the Personal Information Protection Act.

Article 32-3(Processing sensitive information and personally identifiable information) #

(1) The State and local governments (including any person entrusted with relevant duties, where the relevant duties are entrusted) may process data containing information on health prescribed in Article 23 of the Personal Information Protection Act and resident registration numbers, passport numbers, or alien registration numbers prescribed in subparagraph 1, 2, or 4 of Article 19 of the Enforcement Decree of that Act, if unavoidable to conduct the following: <Amended on Jun. 2, 2020; Jun. 8, 2021; Aug. 3, 2021>

1. Affairs concerning the medical treatment and protection of patients of infectious diseases, etc. under Article 4(2)2 of the Act;

2. Affairs concerning training projects of professionals for the prevention and control of infectious diseases under Article 4(2)8 of the Act;

3. Affairs concerning international cooperation for the exchange, etc. of infectious disease control information under Article 4(2)9 of the Act.

(2) The Minister of Health and Welfare, the Commissioner of the Korea Disease Control and Prevention Agency, the Mayor/Do Governor, the head of a Si/Gun/Gu (including a person to whom the relevant authority or duties have been delegated or entrusted, if such authority or duties have been delegated or entrusted), the director of a public health center, or an institutions of sentinel surveillance of infectious diseases designated under Article 16 (1) of the Act may process materials containing personal information under the provisions, with the exception of the subparagraphs, of paragraph (1), if it is unavoidable for performing the following business affairs: <Amended on Jun. 28, 2016; Jun. 2, 2020; Sept. 11, 2020; Dec. 29, 2020; Aug. 3, 2021; Sep. 30, 2025>

1. Business affairs regarding establishing and operating the medical resource information system under Article 8-2 of the Act;

1-2. Business affairs regarding the reporting, detection, and management of patients of infectious diseases, etc. under Articles 11 through 13 and 15 of the Act;

2. Affairs concerning the sentinel surveillance, etc. of infectious diseases under Article 16 of the Act;

3. Affairs concerning fact-finding surveys conducted under Article 17 of the Act;

4. Affairs concerning epidemiological investigations conducted under Article 18 of the Act;

5. Affairs concerning medical examinations conducted under Article 19 of the Act;

Article 32-4(Review of regulation) #

(1) The Minister of Health and Welfare shall examine the appropriateness of the standards for designation of the central infectious disease hospital referred to in Article 1-3(2) and Appendix 1 every five years, counting from January 1, 2022 (referring to the period that ends on the day before January 1 of every fifth year) and shall take measures, such as making improvements.

(2) The Commissioner of the Korea Disease Control and Prevention Agency shall examine the appropriateness of the following matters every three years, counting from January 1, 2022 (referring to the period that ends on the day before January 1 of every third year) and shall take measures, such as making improvements:

1. The standards for designating regional infectious disease hospitals under Article 1-4(2) and Appendix 1-2;

2. The safety control guidelines for high-risk pathogen handling facilities under Article 19-6(1);

3. The scope of information requested under Article 32-2.

[This Article Added on Mar. 8, 2022]

Article 33(Imposition of administrative fines) #

The criteria for imposing administrative fines under Article 83(1) and (4) of the Act shall be specified in Appendix 3. <Amended on Jun. 12, 2018; Oct. 13, 2020>

[This Article Wholly Amended on Jan. 6, 2016]